Anokion SA is a Swiss biotechnology company that aims to make a meaningful difference in the lives of patients suffering from autoimmune diseases by restoring normal immune tolerance. The company is focused on both prevalent and rare autoimmune diseases, including celiac disease, multiple sclerosis and type 1 diabetes. Anokion’s distinct approach leverages the company’s immune-based platform, which targets natural pathways in the liver to restore immune tolerance and address the underlying cause of autoimmune disease.
Location: United States, Massachusetts, Cambridge
Employees: 11-50
Total raised: $112.59M
Founded date: 2010
Investors 1
| Date | Name | Website |
| - | VentureLab | venturelab... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 07.11.2022 | - | $35M | - |
| 13.09.2019 | - | $40M | - |
| 09.05.2014 | Series A | $37.59M | - |
Mentions in press and media 21
| Date | Title | Description | Source |
| 10.05.2023 | Biotech startups turn gear into Phase 2 clinical trials | Bioversys focuses on the research and development of small molecules for multidrug-resistant bacte... | startuptic... |
| 21.10.2022 | Pfizer invests $35 million in Anokion | Based at the EPFL Innovation Park, with offices in the US, Anokion is dedicated to changing the li... | startuptic... |
| 18.10.2022 | Anokion Raises $35M in Equity Funding from Pfizer | Anokion, a Lausanne, Switzerland-based clinical-stage biotechnology company, raised $35M in Equity f... | finsmes.co... |
| 24.03.2021 | Anokion advances second drug candidate into clinical trials | Anokion is a Swiss biotech company focused on both prevalent and rare autoimmune diseases, including... | startuptic... |
| 24.03.2021 | Anokion advances second drug candidate into clinical trials | Anokion is a Swiss biotech company focused on both prevalent and rare autoimmune diseases, includi... | startuptic... |
| 26.02.2021 | Female leaders at the top | EBAMed SA, developer of medical technologies to transform the treatment of cardiac arrhythmias, ha... | startuptic... |
| 26.02.2021 | Female leaders at the top | EBAMed SA, developer of medical technologies to transform the treatment of cardiac arrhythmias, has ... | startuptic... |
| 27.01.2020 | A flourishing year for the EPFL and its spin-offs | The École Polytechnique Fédérale de Lausanne (EPFL) is one of the leading research institutes in S... | startuptic... |
| 27.01.2020 | A flourishing year for the EPFL and its spin-offs | The École Polytechnique Fédérale de Lausanne (EPFL) is one of the leading research institutes in Swi... | startuptic... |
| 22.01.2020 | Anokion receives FDA Clearance | Based in Ecublens (VD), Anokion is developing a new therapy for treating rare autoimmune diseases su... | startuptic... |
Show more